(4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid(CAS: 104239-97-6)

This compound is regulated under various guidelines depending on its intended use. For industrial use, it must comply with REACH regulations for registration, evaluation, authorization, and restriction of chemicals in the European Union. In the United States, the FDA may require registration for certain pharmaceutical applications, and the EPA may regulate it under the Toxic Substances Control Act for environmental and safety concerns.

Yes, there are alternative reagents and isomers that can be used in synthesis. For example, (4aS,4bR,6aS,7R,9aS,9bS,11aS)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid is a similar compound with different stereochemistry. Other alternatives include using diols and carboxylic acids in condensation reactions.

Research trends for this compound indicate growing interest in its application in pharmaceuticals and materials science. Market demand is increasing due to its potential as a drug candidate and in drug delivery systems. Recent studies focus on its synthesis, properties, and biological activities, particularly in antiviral and anticancer applications.

Waste containing this compound should be handled according to hazardous waste regulations. Collection should be done in properly labeled containers and stored in a secure, well-ventilated area. Incineration or professional waste disposal is recommended, and environmental precautions such as containment and monitoring of emissions must be observed to prevent contamination. Compliance with local and international environmental protection standards is essential.